General MedicationsINJECTIONGeneric

GEREF

SERMORELIN ACETATE

Standard Dose

EQ 0.05MG BASE/AMP **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview GEREF is listed in Drugs@FDA under application 019863 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient SERMORELIN ACETATE Form and strength INJECTABLE;INJECTION - EQ 0.05MG BASE/AMP **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor EMD SERONO Submission history Latest submission status date: 2001-10-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview GEREF is listed in Drugs@FDA under application 019863 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SERMORELIN ACETATE Form and strength INJECTABLE;INJECTION - EQ 0.05MG BASE/AMP **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor EMD SERONO Submission history Latest submission status date: 2001-10-02 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.